The conect4children (collaborative network for European clinical trials for children, (c4c) is large collaborative pediatric network that will facilitate the development of new drugs and other therapies for the entire pediatric population in Europe.
c4c aims to enhance the competitiveness of Europe as a critical region for developing medicines for children by using existing expertise, patient access and developing common processes to be applied to disease natural history studies, registries, studies of new therapies and comparisons of existing therapies.
The consortium is a novel collaboration between academic and private sectors that includes 33 academic and 10 industry partners from 20 European countries, more than 50 third parties and around 500 affiliated partners.
The project is coordinated and led by: Fondazione PENTA – for the treatment and care of children with HIV – ONLUS, The University of Liverpool, Janssen Pharmaceutical NV, Bayer AG.
